 | • レポートコード：MRC2-11QY00189 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はチクングニア熱治療薬のグローバル市場について調査・分析したレポートです。種類別（チクングニア熱ワクチン、モノクローナル抗体、ポリ硫酸ペントサンナトリウム、合成ペプチド、その他）市場規模、用途別（クリニック、研究機関、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別チクングニア熱治療薬の競争状況、市場シェア ・世界のチクングニア熱治療薬市場：種類別市場規模 2015年-2020年（チクングニア熱ワクチン、モノクローナル抗体、ポリ硫酸ペントサンナトリウム、合成ペプチド、その他） ・世界のチクングニア熱治療薬市場：種類別市場規模予測 2021年-2026年（チクングニア熱ワクチン、モノクローナル抗体、ポリ硫酸ペントサンナトリウム、合成ペプチド、その他） ・世界のチクングニア熱治療薬市場：用途別市場規模 2015年-2020年（クリニック、研究機関、病院） ・世界のチクングニア熱治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、研究機関、病院） ・北米のチクングニア熱治療薬市場分析：米国、カナダ ・ヨーロッパのチクングニア熱治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのチクングニア熱治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のチクングニア熱治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのチクングニア熱治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abivax SA、Arno Therapeutics Inc、Bharat Biotech International Ltd、Ennaid Therapeutics LLC、Etubics Corp、Hawaii Biotech Inc、Indian Immunologicals Ltd、Inovio Pharmaceuticals Inc、Integral Molecular Inc、Integrated BioTherapeutics Inc、Moderna Therapeutics Inc、Mymetics Corp、Nanotherapeutics Inc、Paradigm Biopharmaceuticals Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chikungunya Fever Drugs Market
The global Chikungunya Fever Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chikungunya Fever Drugs Scope and Market Size
Chikungunya Fever Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chikungunya Fever Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chikungunya Fever Drugs market is segmented into
Chikungunya Vaccine
Monoclonal Antibodies
Pentosan Polysulfate Sodium
Synthetic Peptides
Others
Segment by Application, the Chikungunya Fever Drugs market is segmented into
Clinc
Research Institution
Hospital
Regional and Country-level Analysis
The Chikungunya Fever Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chikungunya Fever Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chikungunya Fever Drugs Market Share Analysis
Chikungunya Fever Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chikungunya Fever Drugs business, the date to enter into the Chikungunya Fever Drugs market, Chikungunya Fever Drugs product introduction, recent developments, etc.
The major vendors covered:
Abivax SA
Arno Therapeutics Inc
Bharat Biotech International Ltd
Ennaid Therapeutics LLC
Etubics Corp
Hawaii Biotech Inc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Integrated BioTherapeutics Inc
Moderna Therapeutics Inc
Mymetics Corp
Nanotherapeutics Inc
Paradigm Biopharmaceuticals Ltd
1 Study Coverage
1.1 Chikungunya Fever Drugs Product Introduction
1.2 Market Segments
1.3 Key Chikungunya Fever Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chikungunya Fever Drugs Market Size Growth Rate by Type
1.4.2 Chikungunya Vaccine
1.4.3 Monoclonal Antibodies
1.4.4 Pentosan Polysulfate Sodium
1.4.5 Synthetic Peptides
1.4.6 Others
1.5 Market by Application
1.5.1 Global Chikungunya Fever Drugs Market Size Growth Rate by Application
1.5.2 Clinc
1.5.3 Research Institution
1.5.4 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chikungunya Fever Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chikungunya Fever Drugs Revenue 2015-2026
2.1.2 Global Chikungunya Fever Drugs Sales 2015-2026
2.2 Global Chikungunya Fever Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chikungunya Fever Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chikungunya Fever Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chikungunya Fever Drugs Competitor Landscape by Players
3.1 Chikungunya Fever Drugs Sales by Manufacturers
3.1.1 Chikungunya Fever Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chikungunya Fever Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chikungunya Fever Drugs Revenue by Manufacturers
3.2.1 Chikungunya Fever Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chikungunya Fever Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chikungunya Fever Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chikungunya Fever Drugs Revenue in 2019
3.2.5 Global Chikungunya Fever Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chikungunya Fever Drugs Price by Manufacturers
3.4 Chikungunya Fever Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chikungunya Fever Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chikungunya Fever Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chikungunya Fever Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chikungunya Fever Drugs Market Size by Type (2015-2020)
4.1.1 Global Chikungunya Fever Drugs Sales by Type (2015-2020)
4.1.2 Global Chikungunya Fever Drugs Revenue by Type (2015-2020)
4.1.3 Chikungunya Fever Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chikungunya Fever Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chikungunya Fever Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chikungunya Fever Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chikungunya Fever Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chikungunya Fever Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chikungunya Fever Drugs Market Size by Application (2015-2020)
5.1.1 Global Chikungunya Fever Drugs Sales by Application (2015-2020)
5.1.2 Global Chikungunya Fever Drugs Revenue by Application (2015-2020)
5.1.3 Chikungunya Fever Drugs Price by Application (2015-2020)
5.2 Chikungunya Fever Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chikungunya Fever Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chikungunya Fever Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chikungunya Fever Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chikungunya Fever Drugs by Country
6.1.1 North America Chikungunya Fever Drugs Sales by Country
6.1.2 North America Chikungunya Fever Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chikungunya Fever Drugs Market Facts & Figures by Type
6.3 North America Chikungunya Fever Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Chikungunya Fever Drugs by Country
7.1.1 Europe Chikungunya Fever Drugs Sales by Country
7.1.2 Europe Chikungunya Fever Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chikungunya Fever Drugs Market Facts & Figures by Type
7.3 Europe Chikungunya Fever Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chikungunya Fever Drugs by Region
8.1.1 Asia Pacific Chikungunya Fever Drugs Sales by Region
8.1.2 Asia Pacific Chikungunya Fever Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chikungunya Fever Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chikungunya Fever Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chikungunya Fever Drugs by Country
9.1.1 Latin America Chikungunya Fever Drugs Sales by Country
9.1.2 Latin America Chikungunya Fever Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chikungunya Fever Drugs Market Facts & Figures by Type
9.3 Central & South America Chikungunya Fever Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chikungunya Fever Drugs by Country
10.1.1 Middle East and Africa Chikungunya Fever Drugs Sales by Country
10.1.2 Middle East and Africa Chikungunya Fever Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chikungunya Fever Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chikungunya Fever Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Abivax SA
11.1.1 Abivax SA Corporation Information
11.1.2 Abivax SA Description and Business Overview
11.1.3 Abivax SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abivax SA Chikungunya Fever Drugs Products Offered
11.1.5 Abivax SA Related Developments
11.2 Arno Therapeutics Inc
11.2.1 Arno Therapeutics Inc Corporation Information
11.2.2 Arno Therapeutics Inc Description and Business Overview
11.2.3 Arno Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Arno Therapeutics Inc Chikungunya Fever Drugs Products Offered
11.2.5 Arno Therapeutics Inc Related Developments
11.3 Bharat Biotech International Ltd
11.3.1 Bharat Biotech International Ltd Corporation Information
11.3.2 Bharat Biotech International Ltd Description and Business Overview
11.3.3 Bharat Biotech International Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bharat Biotech International Ltd Chikungunya Fever Drugs Products Offered
11.3.5 Bharat Biotech International Ltd Related Developments
11.4 Ennaid Therapeutics LLC
11.4.1 Ennaid Therapeutics LLC Corporation Information
11.4.2 Ennaid Therapeutics LLC Description and Business Overview
11.4.3 Ennaid Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ennaid Therapeutics LLC Chikungunya Fever Drugs Products Offered
11.4.5 Ennaid Therapeutics LLC Related Developments
11.5 Etubics Corp
11.5.1 Etubics Corp Corporation Information
11.5.2 Etubics Corp Description and Business Overview
11.5.3 Etubics Corp Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Etubics Corp Chikungunya Fever Drugs Products Offered
11.5.5 Etubics Corp Related Developments
11.6 Hawaii Biotech Inc
11.6.1 Hawaii Biotech Inc Corporation Information
11.6.2 Hawaii Biotech Inc Description and Business Overview
11.6.3 Hawaii Biotech Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hawaii Biotech Inc Chikungunya Fever Drugs Products Offered
11.6.5 Hawaii Biotech Inc Related Developments
11.7 Indian Immunologicals Ltd
11.7.1 Indian Immunologicals Ltd Corporation Information
11.7.2 Indian Immunologicals Ltd Description and Business Overview
11.7.3 Indian Immunologicals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Indian Immunologicals Ltd Chikungunya Fever Drugs Products Offered
11.7.5 Indian Immunologicals Ltd Related Developments
11.8 Inovio Pharmaceuticals Inc
11.8.1 Inovio Pharmaceuticals Inc Corporation Information
11.8.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.8.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Inovio Pharmaceuticals Inc Chikungunya Fever Drugs Products Offered
11.8.5 Inovio Pharmaceuticals Inc Related Developments
11.9 Integral Molecular Inc
11.9.1 Integral Molecular Inc Corporation Information
11.9.2 Integral Molecular Inc Description and Business Overview
11.9.3 Integral Molecular Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Integral Molecular Inc Chikungunya Fever Drugs Products Offered
11.9.5 Integral Molecular Inc Related Developments
11.10 Integrated BioTherapeutics Inc
11.10.1 Integrated BioTherapeutics Inc Corporation Information
11.10.2 Integrated BioTherapeutics Inc Description and Business Overview
11.10.3 Integrated BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Integrated BioTherapeutics Inc Chikungunya Fever Drugs Products Offered
11.10.5 Integrated BioTherapeutics Inc Related Developments
11.1 Abivax SA
11.1.1 Abivax SA Corporation Information
11.1.2 Abivax SA Description and Business Overview
11.1.3 Abivax SA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abivax SA Chikungunya Fever Drugs Products Offered
11.1.5 Abivax SA Related Developments
11.12 Mymetics Corp
11.12.1 Mymetics Corp Corporation Information
11.12.2 Mymetics Corp Description and Business Overview
11.12.3 Mymetics Corp Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Mymetics Corp Products Offered
11.12.5 Mymetics Corp Related Developments
11.13 Nanotherapeutics Inc
11.13.1 Nanotherapeutics Inc Corporation Information
11.13.2 Nanotherapeutics Inc Description and Business Overview
11.13.3 Nanotherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Nanotherapeutics Inc Products Offered
11.13.5 Nanotherapeutics Inc Related Developments
11.14 Paradigm Biopharmaceuticals Ltd
11.14.1 Paradigm Biopharmaceuticals Ltd Corporation Information
11.14.2 Paradigm Biopharmaceuticals Ltd Description and Business Overview
11.14.3 Paradigm Biopharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Paradigm Biopharmaceuticals Ltd Products Offered
11.14.5 Paradigm Biopharmaceuticals Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chikungunya Fever Drugs Market Estimates and Projections by Region
12.1.1 Global Chikungunya Fever Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chikungunya Fever Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chikungunya Fever Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chikungunya Fever Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chikungunya Fever Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chikungunya Fever Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chikungunya Fever Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chikungunya Fever Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chikungunya Fever Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chikungunya Fever Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chikungunya Fever Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chikungunya Fever Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chikungunya Fever Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chikungunya Fever Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chikungunya Fever Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chikungunya Fever Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chikungunya Fever Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chikungunya Fever Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chikungunya Fever Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chikungunya Fever Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chikungunya Fever Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chikungunya Fever Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chikungunya Fever Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chikungunya Fever Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Chikungunya Fever Drugs Market Segments
Table 2. Ranking of Global Top Chikungunya Fever Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chikungunya Fever Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Chikungunya Vaccine
Table 5. Major Manufacturers of Monoclonal Antibodies
Table 6. Major Manufacturers of Pentosan Polysulfate Sodium
Table 7. Major Manufacturers of Synthetic Peptides
Table 8. Major Manufacturers of Others
Table 9. Global Chikungunya Fever Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Chikungunya Fever Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Chikungunya Fever Drugs Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Chikungunya Fever Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Chikungunya Fever Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Chikungunya Fever Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Chikungunya Fever Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Chikungunya Fever Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Chikungunya Fever Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chikungunya Fever Drugs as of 2019)
Table 18. Chikungunya Fever Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Chikungunya Fever Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Chikungunya Fever Drugs Price (2015-2020) (USD/Pcs)
Table 21. Chikungunya Fever Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Chikungunya Fever Drugs Product Type
Table 23. Date of International Manufacturers Enter into Chikungunya Fever Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 26. Global Chikungunya Fever Drugs Sales Share by Type (2015-2020)
Table 27. Global Chikungunya Fever Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Chikungunya Fever Drugs Revenue Share by Type (2015-2020)
Table 29. Chikungunya Fever Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 31. Global Chikungunya Fever Drugs Sales Share by Application (2015-2020)
Table 32. North America Chikungunya Fever Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. North America Chikungunya Fever Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Chikungunya Fever Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Chikungunya Fever Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 37. North America Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 39. North America Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Chikungunya Fever Drugs Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Chikungunya Fever Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Chikungunya Fever Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Chikungunya Fever Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Chikungunya Fever Drugs Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Chikungunya Fever Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Chikungunya Fever Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Chikungunya Fever Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Chikungunya Fever Drugs Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Chikungunya Fever Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Chikungunya Fever Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Chikungunya Fever Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Chikungunya Fever Drugs Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Chikungunya Fever Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Chikungunya Fever Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Chikungunya Fever Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Chikungunya Fever Drugs Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Chikungunya Fever Drugs Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Table 72. Abivax SA Corporation Information
Table 73. Abivax SA Description and Major Businesses
Table 74. Abivax SA Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Abivax SA Product
Table 76. Abivax SA Recent Development
Table 77. Arno Therapeutics Inc Corporation Information
Table 78. Arno Therapeutics Inc Description and Major Businesses
Table 79. Arno Therapeutics Inc Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Arno Therapeutics Inc Product
Table 81. Arno Therapeutics Inc Recent Development
Table 82. Bharat Biotech International Ltd Corporation Information
Table 83. Bharat Biotech International Ltd Description and Major Businesses
Table 84. Bharat Biotech International Ltd Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bharat Biotech International Ltd Product
Table 86. Bharat Biotech International Ltd Recent Development
Table 87. Ennaid Therapeutics LLC Corporation Information
Table 88. Ennaid Therapeutics LLC Description and Major Businesses
Table 89. Ennaid Therapeutics LLC Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Ennaid Therapeutics LLC Product
Table 91. Ennaid Therapeutics LLC Recent Development
Table 92. Etubics Corp Corporation Information
Table 93. Etubics Corp Description and Major Businesses
Table 94. Etubics Corp Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Etubics Corp Product
Table 96. Etubics Corp Recent Development
Table 97. Hawaii Biotech Inc Corporation Information
Table 98. Hawaii Biotech Inc Description and Major Businesses
Table 99. Hawaii Biotech Inc Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Hawaii Biotech Inc Product
Table 101. Hawaii Biotech Inc Recent Development
Table 102. Indian Immunologicals Ltd Corporation Information
Table 103. Indian Immunologicals Ltd Description and Major Businesses
Table 104. Indian Immunologicals Ltd Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Indian Immunologicals Ltd Product
Table 106. Indian Immunologicals Ltd Recent Development
Table 107. Inovio Pharmaceuticals Inc Corporation Information
Table 108. Inovio Pharmaceuticals Inc Description and Major Businesses
Table 109. Inovio Pharmaceuticals Inc Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Inovio Pharmaceuticals Inc Product
Table 111. Inovio Pharmaceuticals Inc Recent Development
Table 112. Integral Molecular Inc Corporation Information
Table 113. Integral Molecular Inc Description and Major Businesses
Table 114. Integral Molecular Inc Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Integral Molecular Inc Product
Table 116. Integral Molecular Inc Recent Development
Table 117. Integrated BioTherapeutics Inc Corporation Information
Table 118. Integrated BioTherapeutics Inc Description and Major Businesses
Table 119. Integrated BioTherapeutics Inc Chikungunya Fever Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Integrated BioTherapeutics Inc Product
Table 121. Integrated BioTherapeutics Inc Recent Development
Table 122. Moderna Therapeutics Inc Corporation Information
Table 123. Moderna Therapeutics Inc Description and Major Businesses
Table 124. Moderna Therapeutics Inc Chikungunya Fever Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Moderna Therapeutics Inc Product
Table 126. Moderna Therapeutics Inc Recent Development
Table 127. Mymetics Corp Corporation Information
Table 128. Mymetics Corp Description and Major Businesses
Table 129. Mymetics Corp Chikungunya Fever Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Mymetics Corp Product
Table 131. Mymetics Corp Recent Development
Table 132. Nanotherapeutics Inc Corporation Information
Table 133. Nanotherapeutics Inc Description and Major Businesses
Table 134. Nanotherapeutics Inc Chikungunya Fever Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Nanotherapeutics Inc Product
Table 136. Nanotherapeutics Inc Recent Development
Table 137. Paradigm Biopharmaceuticals Ltd Corporation Information
Table 138. Paradigm Biopharmaceuticals Ltd Description and Major Businesses
Table 139. Paradigm Biopharmaceuticals Ltd Chikungunya Fever Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Paradigm Biopharmaceuticals Ltd Product
Table 141. Paradigm Biopharmaceuticals Ltd Recent Development
Table 142. Global Chikungunya Fever Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 143. Global Chikungunya Fever Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global Chikungunya Fever Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global Chikungunya Fever Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: Chikungunya Fever Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. North America: Chikungunya Fever Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: Chikungunya Fever Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Europe: Chikungunya Fever Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: Chikungunya Fever Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 151. Asia Pacific: Chikungunya Fever Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: Chikungunya Fever Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Latin America: Chikungunya Fever Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: Chikungunya Fever Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. Middle East and Africa: Chikungunya Fever Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Chikungunya Fever Drugs Players
Table 160. Chikungunya Fever Drugs Customers List
Table 161. Chikungunya Fever Drugs Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Chikungunya Fever Drugs Product Picture
Figure 2. Global Chikungunya Fever Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Chikungunya Vaccine Product Picture
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Pentosan Polysulfate Sodium Product Picture
Figure 6. Synthetic Peptides Product Picture
Figure 7. Others Product Picture
Figure 8. Global Chikungunya Fever Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Clinc
Figure 10. Research Institution
Figure 11. Hospital
Figure 12. Chikungunya Fever Drugs Report Years Considered
Figure 13. Global Chikungunya Fever Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Chikungunya Fever Drugs Sales 2015-2026 (K Pcs)
Figure 15. Global Chikungunya Fever Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Chikungunya Fever Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Chikungunya Fever Drugs Sales Market Share by Region in 2019
Figure 18. Global Chikungunya Fever Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Chikungunya Fever Drugs Revenue Market Share by Region in 2019
Figure 20. Global Chikungunya Fever Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Chikungunya Fever Drugs Revenue in 2019
Figure 22. Chikungunya Fever Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Chikungunya Fever Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Chikungunya Fever Drugs Sales Market Share by Type in 2019
Figure 25. Global Chikungunya Fever Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Chikungunya Fever Drugs Revenue Market Share by Type in 2019
Figure 27. Global Chikungunya Fever Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Chikungunya Fever Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Chikungunya Fever Drugs Sales Market Share by Application in 2019
Figure 30. Global Chikungunya Fever Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Chikungunya Fever Drugs Revenue Market Share by Application in 2019
Figure 32. North America Chikungunya Fever Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Chikungunya Fever Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Chikungunya Fever Drugs Sales Market Share by Country in 2019
Figure 35. North America Chikungunya Fever Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Chikungunya Fever Drugs Market Share by Type in 2019
Figure 41. North America Chikungunya Fever Drugs Market Share by Application in 2019
Figure 42. Europe Chikungunya Fever Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Chikungunya Fever Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Chikungunya Fever Drugs Sales Market Share by Country in 2019
Figure 45. Europe Chikungunya Fever Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Chikungunya Fever Drugs Market Share by Type in 2019
Figure 57. Europe Chikungunya Fever Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Chikungunya Fever Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Chikungunya Fever Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Chikungunya Fever Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Chikungunya Fever Drugs Revenue Market Share by Region in 2019
Figure 62. China Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Chikungunya Fever Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Chikungunya Fever Drugs Market Share by Application in 2019
Figure 86. Latin America Chikungunya Fever Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Chikungunya Fever Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Chikungunya Fever Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Chikungunya Fever Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Chikungunya Fever Drugs Market Share by Type in 2019
Figure 97. Latin America Chikungunya Fever Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Chikungunya Fever Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Chikungunya Fever Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Chikungunya Fever Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Chikungunya Fever Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Chikungunya Fever Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Chikungunya Fever Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Chikungunya Fever Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Chikungunya Fever Drugs Market Share by Application in 2019
Figure 110. North America Chikungunya Fever Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Chikungunya Fever Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Chikungunya Fever Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Chikungunya Fever Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Chikungunya Fever Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Chikungunya Fever Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Chikungunya Fever Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Chikungunya Fever Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Chikungunya Fever Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Chikungunya Fever Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
痛み・発熱緩和薬の世界市場（～2026年） The demand for Pain and Fever Relief Drugs will continue to grow in the next few years. Market Analysis and Insights: Global Pain and Fever Relief Drugs Market The global Pain and Fever Relief Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…- 間欠的発熱症候群の世界市場（～2026年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …
- Q熱の世界市場（～2026年） Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases. The Ame…
- リウマチ熱治療の世界市場（～2026年） Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition. …
- マールブルグ出血熱治療薬の世界市場（～2026年） Market Analysis and Insights: Global Marburg Hemorrhagic Fever Drug Market The global Marburg Hemorrhagic Fever Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Marburg Hemorrhagic Fever Drug Scope and Market Size …